CD19 and B-cell non-Hodgkin lymphoma: Simultaneously targeting CD19, naturally occurring on B-cell lineage and CD47, commonly expressed by tumor cells as a means to avoid macrophage phagocytosis, it destroys tumor cells in B-cell lymphoma, reducing the killing of regular B cells [12].